Double-blind, placebo-controlled study on the effect of the aldosterone receptor antagonist spironolactone in patients who have persistent proteinuria and are on long-term angiotensin-converting enzyme inhibitor therapy, with or without an angiotens (Q80796915)
Jump to navigation
Jump to search
scientific article published on 01 February 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Double-blind, placebo-controlled study on the effect of the aldosterone receptor antagonist spironolactone in patients who have persistent proteinuria and are on long-term angiotensin-converting enzyme inhibitor therapy, with or without an angiotens |
scientific article published on 01 February 2006 |
Statements
Double-blind, placebo-controlled study on the effect of the aldosterone receptor antagonist spironolactone in patients who have persistent proteinuria and are on long-term angiotensin-converting enzyme inhibitor therapy, with or without an angiotensin II receptor blocker (English)
Anastasia Chrysostomou
Eugenia Pedagogos
Lachlan MacGregor
1 reference
1 reference